Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sanofi
Sanofi
Sanofi reveals setback for cancer drug acquired in Synthorx buyout
BioPharma Dive
Fri, 10/28/22 - 10:56 am
Sanofi
Synthorx
M&A
SAR444245
cancer
Sanofi sees faster profit growth on Dupixent, flu vaccine demand
Yahoo/Reuters
Fri, 10/28/22 - 10:48 am
Sanofi
earnings
Dupixent
vaccines
Sanofi and BioMed X Partner to Predict Efficacy with Virtual Patient Populations
BioSpace
Mon, 10/24/22 - 11:03 pm
BioMed X
Sanofi
R&D
artificial intelligence
virtual patients
Sanofi, Regeneron team with Broadway actor for digital severe asthma program
Medical Marketing and Media
Wed, 10/19/22 - 10:54 pm
asthma
severe asthma
Sanofi
Regeneron
pharma marketing
Novartis, GSK and Sanofi Scale Back on Operations and Labor Forces Overseas - Updated
BioSpace
Mon, 10/17/22 - 10:46 am
Novartis
GSK
Sanofi
layoffs
J&J, following in Sanofi's footsteps, tasks i2o with oral delivery of large molecules
Fierce Pharma
Thu, 10/13/22 - 11:50 pm
i20 Therapeutics
Sanofi
JNJ
large molecule drugs
Dupixent Shows Promise as First Treatment for Childhood EoE
BioSpace
Wed, 10/12/22 - 10:33 am
Dupixent
Sanofi
Regeneron
pediatric
clinical trials
eosinophilic esophagitis
The gloom deepens for biopharma stocks
EP Vantage
Mon, 10/10/22 - 06:54 pm
biopharma stocks
AbbVie
Alnylam
AstraZeneca
Biogen
CRISPR Therapeutics
Daiichi Sankyo
Eisai
Eli Lilly
GSK
Intellia Therapeutics
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Anticipating FDA Yes, Provention Inks Co-Promotion Deal with Sanofi for T1D Drug
BioSpace
Thu, 10/6/22 - 07:07 pm
Provention Bio
Sanofi
type 1 diabetes
teplizumab
Sanofi, miRecule Ink Muscular Dystrophy Research Deal Worth up to $430M
BioSpace
Tue, 10/4/22 - 11:43 pm
Sanofi
miRecule
myotonic muscular dystrophy
Sanofi licenses a preclinical genetic disease drug from an unknown biotech spun out of the NIH
Endpoints
Tue, 10/4/22 - 10:47 am
Sanofi
antibody-RNA conjugate
miRecule
FSHD
FDA approves Sanofi and Regeneron’s Dupixent to treat prurigo nodularis
Pharmaceutical Business Review
Thu, 09/29/22 - 10:05 am
Sanofi
Regeneron
Dupixent
prurigo nodularis
FDA
Sanofi and Jennifer Doudna-Founded Scribe ink $1B CRISPR cell therapy deal
Pharma Live
Tue, 09/27/22 - 10:23 am
Sanofi
Scribe Therapeutics
CRISPR
Jennifer Doudna
gene editing
Biden admin says Supreme Court should reject Amgen's petition to take up Repatha patent case
Fierce Pharma
Thu, 09/22/22 - 11:14 pm
Amgen
patents
Supreme Court
Repatha
Sanofi
Regeneron
Sanofi, AZ's blockbuster hopeful RSV med nears first approval as showdown with Pfizer, GSK looms
Fierce Pharma
Fri, 09/16/22 - 10:54 am
Sanofi
AstraZeneca
Pfizer
GSK
nirsevimab
Beyfortus
RSV
Sanofi’s asthma therapy shows consistent safety profile in Phase III trial
Clinical Trials Arena
Tue, 09/6/22 - 05:06 pm
Sanofi
Dupixent
pediatric
clinical trials
severe asthma
asthma
Medtech takes on pain
EP Vantage
Tue, 09/6/22 - 10:58 am
Medtech
pain
devices
Abbott Labs
Medtronic
Sanofi
Redo Neurosystems
Boston Scientific
Sanofi's rare disease drug Xenpozyme scores FDA approval after nods in Japan and Europe
Fierce Pharma
Wed, 08/31/22 - 10:23 pm
Sanofi
Xenpozyme
Niemann-Pick disease
FDA
Former Kadmon consultant pleads guilty to insider trading ahead of Sanofi buyout
Fierce Pharma
Wed, 08/24/22 - 10:42 am
Sanofi
Kadmon
insider trading
legal
DOJ
As Sanofi's SERD falls, Menarini’s advances with EU review
Fierce Biotech
Fri, 08/19/22 - 10:42 am
Sanofi
Menarini
Europe
SERD
breast cancer
elacstrant
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »